Effect of pravastatin on plasma sterols and oxysterols in men

OBJECTIVES: The HMG-CoA reductase inhibitors, or statins, are well established in the prevention and treatment of coronary artery disease, mainly by lowering low-density lipoprotein (LDL) cholesterol levels. These compounds are structurally similar, but differ in their lipophilicity. Several studies...

Full description

Bibliographic Details
Published in:European journal of clinical pharmacology, Vol. 62, No. 1 (2006), p. 9-14
Main Author: Thelen, Karin M (Author)
Other Involved Persons: Lütjohann, Dieter ; Vesalainen, Risto ; Janatuinen, Tuula ; Knuuti, Juhani ; von Bergmann, Klaus ; Lehtimäki, Terho ; Laaksonen, Reijo
Format: Article
Language:English
ISSN:1432-1041
Item Description:Date Completed 16.01.2007
Date Revised 13.11.2018
published: Print-Electronic
Citation Status MEDLINE
Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Subjects:
Other Editions:Show all 2 Editions
QR Code: Show QR Code